Grown Rogue International (GRUSF) Shares Outstanding (Diluted) (2009 - 2026)
Grown Rogue International (GRUSF) Shares Outstanding (Diluted) (2009 - 2026) Analysis & Trends
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Dil.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.76 Bn | 42.79 Bn | - | 4.46 Bn |
| 2 | Teva Pharmaceutical Industries | 43.38 Bn | 39.73 Bn | 2.15 Bn | 1.17 Bn |
| 3 | Zoetis | 31.61 Bn | 29.93 Bn | 1.05 Bn | 417.70 Mn |
| 4 | Takeda Pharmaceutical | 28.64 Bn | 22.84 Bn | 5.10 Bn | 1.58 Bn |
| 5 | United Therapeutics | 22.20 Bn | 19.54 Bn | 683.80 Mn | 45.80 Mn |
| 6 | Viatris | 18.82 Bn | 17.93 Bn | 1.46 Bn | 1.16 Bn |
| 7 | Neurocrine Biosciences | 15.67 Bn | 15.28 Bn | 935.80 Mn | 104.20 Mn |
| 8 | Elanco Animal Health | 12.11 Bn | 11.58 Bn | 798.00 Mn | 505.90 Mn |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | 833.33 Mn |
| 10 | Grown Rogue International | 114.97 Mn | 109.89 Mn | 5.37 Mn | 249.94 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 249.94 Mn |
| Mar 31, 2026 | 249.91 Mn |
| Dec 31, 2025 | 250.86 Mn |
| Sep 30, 2025 | 255.55 Mn |
| Jun 30, 2025 | 256.53 Mn |
| Mar 31, 2025 | 231.80 Mn |
| Dec 31, 2024 | 209.44 Mn |
| Sep 30, 2024 | 232.05 Mn |
| Jun 30, 2024 | 243.74 Mn |
| Mar 31, 2024 | 214.05 Mn |
| Dec 31, 2023 | 214.05 Mn |
| Oct 31, 2023 | 172.71 Mn |
| Jul 31, 2023 | 170.83 Mn |
| Apr 30, 2023 | 170.83 Mn |
| Jan 31, 2023 | 169.19 Mn |
| Oct 31, 2022 | 169.19 Mn |
| Jan 31, 2022 | 135.23 Mn |
| Oct 31, 2021 | 135.23 Mn |
| Jul 31, 2021 | 5.28 Mn |
| Apr 30, 2021 | 5.28 Mn |